HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katarzyna Kotulska Selected Research

nusinersen

7/2022Safety, tolerability, and efficacy of a widely available nusinersen program for Polish children with Spinal Muscular Atrophy.
1/2021Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katarzyna Kotulska Research Topics

Disease

64Tuberous Sclerosis (Bourneville's Disease)
11/2022 - 02/2004
29Astrocytoma (Pilocytic Astrocytoma)
11/2022 - 02/2004
21Epilepsy (Aura)
01/2022 - 04/2011
20Neoplasms (Cancer)
01/2021 - 12/2003
19Seizures (Absence Seizure)
01/2022 - 08/2007
11Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 02/2004
8Drug Resistant Epilepsy
01/2022 - 04/2011
7Glioma (Gliomas)
12/2021 - 01/2011
6Brain Neoplasms (Brain Tumor)
11/2022 - 04/2010
6Intellectual Disability (Idiocy)
01/2022 - 09/2011
5Autism Spectrum Disorder
01/2022 - 12/2016
5Angiomyolipoma
06/2016 - 01/2007
5Neuralgia (Stump Neuralgia)
11/2011 - 01/2006
4Neurocutaneous Syndromes (Phakomatoses)
01/2020 - 08/2007
4Carcinogenesis
01/2020 - 04/2010
4Hamartoma
01/2020 - 08/2007
4Neuroma
11/2011 - 01/2006
3Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2015
3Autistic Disorder (Autism)
01/2020 - 01/2017
3Peripheral Nerve Injuries
07/2007 - 01/2006
2Spinal Muscular Atrophy (Progressive Muscular Atrophy)
07/2022 - 01/2021
2Diarrhea
01/2021 - 01/2021
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2021 - 01/2021
2Infections
01/2021 - 04/2015
2Ganglioglioma
01/2021 - 06/2018
2Hydrocephalus (Hydrocephaly)
01/2020 - 12/2014
2Brain Diseases (Brain Disorder)
03/2016 - 01/2016
2Angiofibroma
01/2016 - 07/2013
2Rhabdomyoma
07/2013 - 03/2009
1Neurodevelopmental Disorders
10/2021
1Hyperglycemia
01/2021
1Sleepiness
01/2021
1Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
01/2021
1Multiple Sclerosis
01/2021
1Autoimmune Diseases of the Nervous System
01/2021
1Bronchitis
01/2021
1Anemia
01/2021
1Infantile Spasms (West Syndrome)
01/2021
1Stomatitis
01/2021
1Neutropenia
01/2021
1Cognitive Dysfunction
10/2020
1Focal Cortical Dysplasia
01/2019
1Temporal Lobe Epilepsy
01/2019
1Disseminated Intravascular Coagulation
01/2019
1Hyperlipidemias (Hyperlipidemia)
10/2016
1Bacteremia
01/2016
1Virus Diseases (Viral Diseases)
01/2016
1Sepsis (Septicemia)
04/2015
1Renal Cell Carcinoma (Grawitz Tumor)
04/2015
1Demyelinating Diseases (Demyelinating Disease)
07/2013
1Mitochondrial Diseases (Mitochondrial Disease)
01/2013

Drug/Important Bio-Agent (IBA)

54trans-sodium crocetinate (crocetin)IBA
11/2022 - 12/2004
18EverolimusFDA Link
06/2022 - 01/2012
14TOR Serine-Threonine KinasesIBA
06/2021 - 01/2007
9Pharmaceutical PreparationsIBA
01/2022 - 04/2011
8Sirolimus (Rapamycin)FDA Link
11/2022 - 03/2009
7Anticonvulsants (Antiepileptic Drugs)IBA
01/2022 - 08/2007
7VigabatrinFDA Link
01/2022 - 09/2018
6Tuberous Sclerosis Complex 2 ProteinIBA
01/2018 - 02/2004
6Tuberous Sclerosis Complex 1 ProteinIBA
01/2018 - 02/2004
5Mechanistic Target of Rapamycin Complex 1IBA
10/2021 - 01/2017
4MicroRNAs (MicroRNA)IBA
06/2022 - 09/2016
4Proteins (Proteins, Gene)FDA Link
10/2020 - 04/2010
4MTOR InhibitorsIBA
12/2016 - 01/2016
2nusinersenIBA
07/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2019
2ChromatinIBA
12/2021 - 01/2021
2CytokinesIBA
07/2013 - 08/2012
2Mitochondrial DNA (mtDNA)IBA
01/2013 - 04/2011
2Analgesics (Analgesic Drugs)IBA
07/2007 - 01/2006
2Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2007 - 01/2006
2trkB ReceptorIBA
01/2007 - 01/2006
1Cell Adhesion MoleculesIBA
01/2022
1IronIBA
06/2021
1Histones (Histone)IBA
01/2021
1Oligoclonal BandsIBA
01/2021
1CannabidiolIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1EnzymesIBA
01/2021
1RecQ HelicasesIBA
10/2020
1Matrix Metalloproteinases (MMPs)IBA
01/2020
1Ion Channels (Ion Channel)IBA
01/2019
1LipidsIBA
10/2016
1Oleic Acid (Oleate)IBA
02/2016
1Growth Hormone (Somatotropin)IBA
02/2016
1Alkaline PhosphataseIBA
01/2016
1I-kappa B KinaseIBA
10/2015
1Glutamate-Cysteine LigaseIBA
07/2015
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2013
1Macrophage Colony-Stimulating FactorIBA
07/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2012
1Endothelin-1 (Endothelin 1)IBA
08/2012

Therapy/Procedure

16Therapeutics
01/2021 - 02/2006
4Drug Therapy (Chemotherapy)
01/2019 - 06/2007
1Treatment Delay
01/2021
1Vagus Nerve Stimulation
01/2021
1Aftercare (After-Treatment)
10/2016
1Ketogenic Diet
02/2016
1Topical Administration
01/2016